Chemiluminescent immunoassay (CLIA) is a biochemical technique used in immunology that is a variation of the standard enzyme immunoassay (EIA). They can also be used as diagnostic tools in medicine, as well as in a variety of other industries such as for food safety and pharmaceutical analysis, environmental monitoring, and many more.
There are two type of chemiluminescence immunoassay methods:
- Indirect CLIA with enzyme markers- An enzyme, typically horse radish peroxidase (HRP) or alkaline phosphatase (AP), is conjugated to a secondary antibody in this common CLIA method.
- Direct CLIA with luminophore markers- To generate a signal, acridinium esters are commonly used as luminophores and are conjugated directly to the primary monoclonal antibody.
Market Dynamics
Market players are focused on supplying products to hospitals and government organizations, this could contribute to the growth of the global chemiluminescence immunoassay market over the forecast period. For instance, on June 22, 2020, Abbott Laboratories, located in Mumbai, India, began to distribute its laboratory-based serology blood test for the detection of the antibody IgG (Immunoglobulin G), which determines whether a person has been infected with the novel coronavirus (COVID-19). Abbott has the capacity to supply millions of tests to India and has delivered antibody tests to leading government and private hospitals and labs in Maharashtra, Delhi, West Bengal, Uttar Pradesh, Jammu & Kashmir, and Gujarat. The SARS-CoV-2 IgG test from Abbott can be used for highly reliable, large-scale antibody testing, as recommended by the ICMR (Indian Council of Medical Research) for the use of IgG CLIA (Chemiluminescence immunoassay) tests.
Market players focused on product launches is expected to propel the growth of the global chemiluminescence immunoassay market. For instance, on July 25, 2019, STRATEC SE, a global company that develops and manufactures analyzer systems and automation systems for in-vitro diagnostics, has taken another step toward diversifying its product portfolio by introducing stand-alone modules and a new chemiluminescence immunoassay KleeYa. The KleeYa analyzer is an open platform system that can be used by a variety of providers.
Market players and government authorities are involved in expanding their global presence by adopting strategies such as acquisitions and collaborations, is expected to drive the growth of the global chemiluminescence immunoassay market. For instance, on November 16, 2020, Biomedical Advanced Research and Development Authority (BARDA), U.S. expanded its existing partnership with DiaSorin Inc. in the development of COVID-19 immunoassays. DiaSorin plans to develop and sell its new fully automated chemiluminescence immunoassay in the U.S. and around the world and obtain regulatory approval for semi-quantitative detection of SARS CoV2 virus IgG antibodies in human serum and plasma. The test is designed to help determine the patient's exposure and immune status to the SARSCoV2 virus and COVID-19.
Key features of the study:
- This report provides an in-depth analysis of global chemiluminescence immunoassay market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global chemiluminescence immunoassay market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostic.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global chemiluminescence immunoassay market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global chemiluminescence immunoassay market
Detailed Segmentation:
- Global Chemiluminescence Immunoassay Market, By Product Type:
- Analyzers
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- Global Chemiluminescence Immunoassay Market, By Application :
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- Global Chemiluminescence Immunoassay Market, By End User:
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
- Global Chemiluminescence Immunoassay Market, By Region:
- North America
- By Product Type:
- Analyzers
- Automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- By End User:
- Hospitals
- Clinical Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
- By Country:
- Latin America
- By Product Type:
- Analyzers
- Automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- By End User:
- Hospitals
- Clinical Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Analyzers
- Automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- By End User:
- Hospitals
- Clinical Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Analyzers
- Automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- By End User:
- Hospitals
- Clinical Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Analyzers
- Automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- By End User:
- Hospitals
- Clinical Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Analyzers
- Automated
- Semi-automated
- Reagents
- Luminophore Markers
- Enzymatic Markers
- Consumables
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
- By End User:
- Hospitals
- Clinical Laboratory
- Pharmaceutical and Biotechnology Companies
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- DiaSorin S.p.A.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Abbott Laboratories
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens Healthineers
- Beckman Coulter Inc.
- F. Hoffmann-La Roche AG
- Inova Diagnostics, Inc.
- Maccura Biotechnology Co., Ltd.
- Tosoh Corporation
- Ortho Clinical Diagnostic
“*” marked represents similar segmentation in other categories in the respective section.